These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 9662740)

  • 21. Effect of zotepine on dopamine, serotonin and noradrenaline release in rat prefrontal cortex.
    Nakamura S; Ago Y; Itoh S; Koyama Y; Baba A; Matsuda T
    Eur J Pharmacol; 2005 Dec; 528(1-3):95-8. PubMed ID: 16321379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain.
    Liang Y; Boules M; Shaw AM; Williams K; Fredrickson P; Richelson E
    Brain Res; 2008 Sep; 1231():6-15. PubMed ID: 18687313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropharmacological profile of EMD 57445, a sigma receptor ligand with potential antipsychotic activity.
    Maj J; Rogóz Z; Skuza G; Mazela H
    Eur J Pharmacol; 1996 Nov; 315(3):235-43. PubMed ID: 8982660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of c-fos gene expression by the selective sigma receptor ligand EMD 57445 in rat brain.
    Dahmen N; Fischer V; Hödl P; Rujescu D; Reuss S; Bartoszyk GD; Hiemke C
    Eur Neuropsychopharmacol; 1996 Aug; 6(3):237-43. PubMed ID: 8880084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. JL13, a pyridobenzoxazepine compound with potential atypical antipsychotic activity, increases extracellular dopamine in the prefrontal cortex, but not in the striatum and the nucleus accumbens of rats.
    Invernizzi R; Garavaglia C; Samanin R
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):298-302. PubMed ID: 10731043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occupancy of striatal D(2)-like dopamine receptors after treatment with the sigma ligand EMD 57445, a putative atypical antipsychotic.
    Gründer G; Müller MJ; Andreas J; Heydari N; Wetzel H; Schlösser R; Schlegel S; Nickel O; Eissner D; Benkert O
    Psychopharmacology (Berl); 1999 Sep; 146(1):81-6. PubMed ID: 10485968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of NPC16377, a potent and selective sigma receptor ligand, on the activity of mesencephalic dopamine-containing neurons in the rat.
    Shepard PD; Lehmann H; Connelly ST
    Eur J Pharmacol; 1994 Nov; 265(3):141-9. PubMed ID: 7875229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine and chronic antipsychotic drug treatment.
    Bowers MB
    Psychopharmacol Bull; 1979 Jan; 15(1):55-6. PubMed ID: 33409
    [No Abstract]   [Full Text] [Related]  

  • 29. A new centrally acting DA-receptor agonist with selectivity for autoreceptors.
    Hjorth S; Carlsson A; Lindberg P
    Psychopharmacol Bull; 1980 Jul; 16(3):85-90. PubMed ID: 7403415
    [No Abstract]   [Full Text] [Related]  

  • 30. Characterization of the sigma ligand panamesine, a potential antipsychotic, by immune response in patients with schizophrenia and by sleep-EEG changes in normal controls.
    Frieboes RM; Murck H; Antonijevic I; Kraus T; Hinze-Selch D; Pollmächer T; Steiger A
    Psychopharmacology (Berl); 1999 Jan; 141(1):107-10. PubMed ID: 9952072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain monoamines are involved in the sedative effects of opiates and neuroleptics.
    Furst S
    Prog Clin Biol Res; 1990; 328():311-4. PubMed ID: 1968267
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antineurotic effect of the hydrazide of O-B-chloroethyl-para-N-dimethylaminophenylphosphinylacetic acid (amfazide)].
    Semin II; Baĭchurina AZ; Garaev RS
    Biull Eksp Biol Med; 1996 Apr; 121(4):423-5. PubMed ID: 8829457
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of some tranquilizers on the content of lactic and pyruvic acids in the rat brain].
    Maté V; Kashshai G
    Ukr Biokhim Zh; 1966; 38(1):81-3. PubMed ID: 5993725
    [No Abstract]   [Full Text] [Related]  

  • 34. A clinical perspective on microdialysis.
    Pickar D
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14 Suppl():S59-62. PubMed ID: 1982972
    [No Abstract]   [Full Text] [Related]  

  • 35. Correlations between the results of pharmacokinetic and pharmacological studies on several pipotiazine esters.
    Julou L; Bourat G; Ducrot R; Fournel J; Garret C; Mottet F
    Therapie; 1973; 28(3):475-99. PubMed ID: 4149220
    [No Abstract]   [Full Text] [Related]  

  • 36. The turnover of 3,4-dihydroxyphenylethylamine (dopamine) in the brain.
    Sharman DF
    J Physiol; 1966 Oct; 186(2):69P-70P. PubMed ID: 5972132
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of EMD 57445, the selective sigma receptor ligand, on the turnover and release of dopamine.
    Skuza G; Gołembiowska K; Wedzony K
    Pol J Pharmacol; 1998; 50(1):61-4. PubMed ID: 9662740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of local intracerebral administration of EMD 57445, a selective sigma receptor ligand, on the locomotor activity of the rat.
    Skuza G; Kolasiewicz W; Dziedzicka-Wasylewska M; Margas W
    Pol J Pharmacol; 1998; 50(6):399-406. PubMed ID: 10385922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EMD 57445, the selective sigma receptor ligand, has no effect on the 5-hydroxytryptamine system.
    Skuza G; Rogóz Z; Gołembiowska K
    Pol J Pharmacol; 1997; 49(6):489-93. PubMed ID: 9566054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effects of deramciclane, ritanserin and buspirone on extracellular dopamine and its metabolites in striatum and nucleus accumbens of freely moving rats.
    Kääriäinen TM; Lehtonen M; Forsberg MM; Savolainen J; Käenmäki M; Männistö PT
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):50-8. PubMed ID: 17971064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.